VEON Ltd.
VEONdata completeness 88%11 fiscal years on fileData notes: no data for concept 'interestExpense'
VEON Ltd. earns about 15% on invested capital, but has diluted owners by 5% over 5 years — worth asking whether the growth reaches owners. The applicable estimate puts fair value near $2.73 a share.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $3.85B1 | $3.76B2 | $3.7B3 | $4B3 | $4.4B3 |
| Net income | $801M4 | −$9M5 | −$2.45B6 | $487M6 | $591M6 |
| Operating cash flow | — | — | — | — | — |
| Capital expenditure | $699M7 | $634M8 | $531M9 | $627M9 | $733M9 |
| Free cash flow (derived) | — | — | — | — | — |
| Total debt | $7.6B10 | $6.67B11 | $3.71B12 | $3.35B13 | $3.14B13 |
| Cash & equivalents | $2.25B14 | $3.11B15 | $1.9B16 | $1.69B17 | $1.73B17 |
| Diluted shares | 1.76B | 1.76B | 1.76B | 1.85B | 1.85B |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $7.25 of net worth that earned you $3.2 last year, against $17 of debt.
It earned an average 15% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is up 5% over 5 years — owners have been diluted. Worth asking what they got for it. Total debt has fallen 59% — deleveraging.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
assumptions (8)
- riskFreeRate4.7%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- normalizedEarnings$487M
- growthAssumed0.0%
assumptions (1)
- grahamMultiplier2250.0%
Different models answer different questions — which to trust when →
- 20-F · period ending 2021-12-31 · accession 0001468091-24-000076 (Revenue)
- 20-F · period ending 2022-12-31 · accession 0001468091-25-000058 (Revenue)
- 20-F · period ending 2023-12-31 · accession 0001468091-26-000010 (Revenue)
- 20-F · period ending 2021-12-31 · accession 0001468091-24-000076 (ProfitLoss)
- 20-F · period ending 2022-12-31 · accession 0001468091-25-000058 (ProfitLoss)
- 20-F · period ending 2023-12-31 · accession 0001468091-26-000010 (ProfitLoss)
- 20-F · period ending 2021-12-31 · accession 0001468091-24-000076 (PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities)
- 20-F · period ending 2022-12-31 · accession 0001468091-25-000058 (PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities)
- 20-F · period ending 2023-12-31 · accession 0001468091-26-000010 (PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities)
- 20-F · period ending 2021-12-31 · accession 0001468091-23-000080 (Borrowings)
- 20-F · period ending 2022-12-31 · accession 0001468091-24-000076 (Borrowings)
- 20-F · period ending 2023-12-31 · accession 0001468091-25-000058 (Borrowings)
- 20-F · period ending 2024-12-31 · accession 0001468091-26-000010 (Borrowings)
- 20-F · period ending 2021-12-31 · accession 0001468091-23-000080 (CashAndCashEquivalents)
- 20-F · period ending 2022-12-31 · accession 0001468091-24-000076 (CashAndCashEquivalents)
- 20-F · period ending 2023-12-31 · accession 0001468091-25-000058 (CashAndCashEquivalents)
- 20-F · period ending 2024-12-31 · accession 0001468091-26-000010 (CashAndCashEquivalents)